Nurofen's 'straight to the souce of pain' claim banned

Nurofen’s manufacturer is faced with a marketing headache after its longstanding claim the drug “goes straight to the source of pain” was ruled misleading.

The Therapeutic Goods Administration has told Reckitt Benckiser it must not use the claims for headache pain in ads for its ibuprofen-based product, after reviewing an earlier finding from last August.

The company disputed